MedTechIndexBETA
The MedTechIndex Briefing

Keep up with MedTechIndex.

A weekly note from Blair, new companies added to the directory, and meaningful updates to existing profiles.

Confirm your email to join. Email privacy

Companies / Fibioseq Medical
Medical device company profile

Fibioseq Medical

Israeli developer of the WristArt total wrist replacement implant.

Manufacturer / DeveloperOrthopedics & MusculoskeletalJoint ReconstructionClinical-stage
Headquarters๐Ÿ‡ฎ๐Ÿ‡ฑAcre, Israel
FoundedNot confirmed
Commercial statusIn developmentWristArt is undergoing clinical development.
EmployeesNot confirmed
Estimated revenueNot confirmed
Official websitefibioseq.com โ†—

Company overview

Fibioseq Medical develops implants for orthopedic extremity reconstruction. Its WristArt program targets painful wrist conditions in which joint replacement may offer an alternative to fusion. The company is based in Acre, Israel.

WristArt uses interconnected implant components designed to preserve bone and accommodate wrist biomechanics. Fibioseq reports the initiation of a first-in-human clinical study and a first implantation. The program remains a clinical-development offering; the reported procedure is separate from routine commercial availability.

[1][2][3][4][5]

Leadership

3 people
Harel ManorChief Executive Officer [1]
Ofer VikinskyChief Technology Officer [1]
Dr. Lauren GorelickChief Medical Officer [1]

Products & regulatory status How does MedTechIndex get this information?

Summary

Fibioseq reports first-in-human use of WristArt. The wrist replacement program is in clinical development. [1]

Regulatory snapshot How to read this snapshot

U.S. FDA
0
510(k) clearances
0
De Novo grants
0
PMA approvals
0
Recall events

Latest recorded source review: 2026-10-30.

Scope: selected product families.

Commercial portfolio snapshot

Device platforms are in clinical development.

Commercial development

WristArt โ€” official manufacturer product image
Image: Fibioseq Medical
Total wrist replacement implant

WristArt โ†—

Interconnected wrist prosthesis components designed for joint replacement while conserving bone stock. [1]

Clinical development

First-in-human implantation reported by Fibioseq.

5 Cited Sources

Accessed 10/30/2026

Last substantive review: 10/30/2026

[1] Company, WristArt and leadership โ†—Fibioseq Medical ยท company website
[2] FDA 510(k) database โ€” research search โ†—U.S. Food and Drug Administration ยท regulatory databaseFDA database search page; not an individual device record.
[3] FDA PMA database โ€” research search โ†—U.S. Food and Drug Administration ยท regulatory databaseFDA database search page; not an individual device record.
[4] FDA medical-device recall database โ€” research search โ†—U.S. Food and Drug Administration ยท regulatory databaseFDA database search page; not an individual device record.
[5] FDA enforcement reports database โ€” research search โ†—U.S. Food and Drug Administration ยท regulatory databaseFDA database search page; not an individual device record.
Company research

Compare companies

Privacy choices

Your saved-company and comparison preferences are stored separately. Changing analytics preferences does not clear them.

About cookies and privacy